Actively Recruiting
Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients
Led by Sunnybrook Health Sciences Centre · Updated on 2025-01-20
25
Participants Needed
1
Research Sites
332 weeks
Total Duration
On this page
Sponsors
S
Sunnybrook Health Sciences Centre
Lead Sponsor
A
AFP Innovation Fund
Collaborating Sponsor
AI-Summary
What this Trial Is About
The investigators propose to use clinically validated patient avatar technology ("PDXovo") that can test multiple drugs against patients' cancers to identify the most promising systemic therapy for each individual.
CONDITIONS
Official Title
Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18+ years
- Diagnosis of metastatic breast cancer regardless of subtype
- Measurable disease based on RECIST 1.1 criteria
- Metastatic disease involving lymph nodes and/or visceral organs
- Willing to undergo biopsy before starting planned systemic therapy
You will not qualify if you...
- Core biopsy of a metastatic site (other than bone) is not feasible or safe
- Unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5
Actively Recruiting
Research Team
K
Katarzyna J Jerzak, MD MSc FRCPC
CONTACT
H
Hon S Leong
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here